Sasanlimab (Anti-PDCD1 / PD-1 / CD279)

Sasanlimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It has potential antineoplastic activities and can be used in the treatment of advanced or metastatic non-small-cell lung cancer and urothelial carcinoma. MW :146.46 KD.

• Supplier: Selleck Chemicals
• Product #: A3038
• Sku #: A3038-1mg*25